PHGE — Biomx Income Statement
0.000.00%
Last trade - 00:00HealthcareSpeculativeMicro CapNeutral
- $11.71m
- -$14.07m
- 29
- 52
- 20
- 24
Annual income statement for Biomx, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 June 30th | 2019 June 30th | 2020 December 31st | 2021 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Total Revenue | 0 | 0 | 0 | 0 |
| Selling / General / Administrative Expenses | ||||
| Research And Development | ||||
| Depreciation and Amortization | ||||
| Other Operating Expenses | ||||
| Total Operating Expenses | 0.001 | 0.405 | 30.3 | 35.5 |
| Operating Profit | -0.001 | -0.405 | -30.3 | -35.5 |
| Total Net Non Operating Interest Income / Expense | ||||
| Other Net Non Operating Costs | ||||
| Net Income Before Taxes | -0.001 | 0.483 | -30.1 | -36.2 |
| Provision for Income Taxes | ||||
| Net Income After Taxes | -0.001 | 0.347 | -30.1 | -36.2 |
| Net Income Before Extraordinary Items | ||||
| Net Income | -0.001 | 0.347 | -30.1 | -36.2 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Diluted Net Income | -0.001 | 0.347 | -30.1 | -36.2 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | -0.001 | 0.174 | -1.3 | -1.39 |
| Dividends per Share |